Genotyping Market Forecast to Grow at 22.3% CAGR to 2020

Aug 27, 2015, 02:00 ET from ReportsnReports

PUNE, India, August 27, 2015 /PRNewswire/ --

Two new genotyping market research reports reviewing the genotyping technology, its application and products for global regions as well as single nucleotide polymorphism (SNP) genotyping industry analysis are now available with ReportsnReports.com.

Complete report on genotyping market by technology, application and by products spread across 200 pages, profiling 10 major companies and supported with 113 tables and 37 figures is now available at http://www.reportsnreports.com/reports/399299-genotyping-market-by-technology-polymerase-chain-reaction-sequencing-microarray-electrophoresis-malditof-application-pharmacogenomics-diagnostic-research-animal-genetics-agricultural-biotechnology-by-products-global-forecast-to-2020.html .

The genotyping market in this report is broadly segmented based on products and services, technology, applications, and end-users. The market, by technology, is segmented into microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others (insitu hybridization). Sequencing market is forecasted to grow at a highest CAGR 27.7% over the forecast period of 2015-2020, owing to its high speed, accuracy, flexibility, and increasing application areas. Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

Growth in this market is attributed to the increasing incidence of genetic diseases & increasing awareness about personalized medicine, technological advancements, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the increasing demand for genetic analysis in animal & plant livestock. However, the lack of appropriate reimbursement policies and a lack of technical know-how are curbing market growth to a certain extent. The reagents & kits market segment accounted for the largest share of 49% of the global genotyping market in 2014. The accessibility of a wide range of reagents and increasing need for genotyping for assessing drug efficacy and safety, to personalize the treatment for chronic diseases, to develop good breeds of animals & plants are some of the factors that are expected to drive the genotyping reagents market.

Emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. The Asia-Pacific genotyping market is expected to grow at a CAGR of 25.4% during the forecast period of 2015-2020. Countries like India, China, and Brazil will majorly drive market growth owing to the introduction of healthcare reforms, rising investments by public and private players to provide improved healthcare services in these countries, and the unmet medical needs of patients suffering from diseases such as cancer, diabetes and cardiovascular disease. Genotyping tests are increasingly being used in drug discovery and development process and to provide personalized therapy, factors that are driving market growth. In addition to this, heavy investments by key manufacturers to offer advanced and innovative products for wider applications are also propelling genotyping market growth.

Genotyping market companies like Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.) are discussed in this research available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=399299 .

The second study titled Global Single Nucleotide Polymorphism (SNP) Genotyping Industry 2015 Market Research Report is spread across 215 pages, profiles 19 companies and is supported with 188 tables and figures. The Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2015 Industry Research Report is a professional and in-depth study on the current state of the Single Nucleotide Polymorphism (SNP) Genotyping industry. It provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The single nucleotide polymorphism (SNP) genotyping market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This SNP genotyping market report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The single nucleotide polymorphism (SNP) genotyping market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 188 tables and figures to support the SNP genotyping market analysis, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies profiled in this research include Affymetrix, Agilent Technologies, Bio Discovery, Beckman Coulter, Bio-Rad Laboratories, Combimatrix, Douglas Scientific, Enzo Life Sciences, Epigendx, Fluidigm, Ge Healthcare, Illumina, Li-Cor Biosciences, Life Technologies, Ocimum Biosolutions, Premier Biosoft, Qiagen, Roche And Sequenom Inc. Comprehensive table of contents and more on this SNP genotyping market research to 2020 is available at http://www.reportsnreports.com/reports/411606-global-single-nucleotide-polymorphism-snp-genotyping-industry-2015-market-research-report.html .

Explore more reports on the biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/ .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect With Us on:  

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: http://www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds:  http: //http://www.reportsnreports.com/feed/l-latestreports.xml


SOURCE ReportsnReports